MAIA Biotechnology annual total assets
2021
2022
2023
2024
2025
MAIA Biotechnology Total Assets Growth & History (MAIA)
MAIA Biotechnology's total assets was $9.7M for fiscal 2025.
View full MAIA Biotechnology company overviewMAIA Biotechnology annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $9.7M | −$450,623 | −4.44% |
| 2024 | 2024-12-31 | $10.2M | $2.6M | +34.21% |
| 2023 | 2023-12-31 | $7.6M | −$4.5M | −37.06% |
| 2022 | 2022-12-31 | $12.0M | $694,841 | +6.13% |
| 2021 | 2021-12-31 | $11.3M | — | — |
MAIA Biotechnology quarterly total assets
Q4.21
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $28.2M | $17.2M | +155.66% |
| Q1 2026 | 2026-03-31 | $35.3M | $23.5M | +197.71% |
| Q4 2025 | 2025-12-31 | $9.7M | −$450,623 | −4.44% |
| Q3 2025 | 2025-09-30 | $11.8M | $2.5M | +27.47% |
| Q2 2025 | 2025-06-30 | $11.0M | −$973,754 | −8.10% |
| Q1 2025 | 2025-03-31 | $11.9M | $3.1M | +36.12% |
| Q4 2024 | 2024-12-31 | $10.2M | $2.6M | +34.21% |
| Q3 2024 | 2024-09-30 | $9.2M | $2.2M | +32.02% |
| Q2 2024 | 2024-06-30 | $12.0M | $1.8M | +17.05% |
| Q1 2024 | 2024-03-31 | $8.7M | −$358,017 | −3.95% |
| Q4 2023 | 2023-12-31 | $7.6M | −$4.5M | −37.06% |
| Q3 2023 | 2023-09-30 | $7.0M | −$7.8M | −52.64% |
| Q2 2023 | 2023-06-30 | $10.3M | $509,109 | +5.22% |
| Q1 2023 | 2023-03-31 | $9.1M | — | — |
| Q4 2022 | 2022-12-31 | $12.0M | $694,841 | +6.13% |
| Q3 2022 | 2022-09-30 | $14.8M | — | — |
| Q2 2022 | 2022-06-30 | $9.8M | — | — |
| Q4 2021 | 2021-12-31 | $11.3M | — | — |
MAIA Biotechnology total assets trends
Between the periods ended 2021-12-31 and 2025-12-31, MAIA Biotechnology's total assets decreased from $11.3M to $9.7M, a change of −$1.6M. The latest reported quarter, Q2 2026, shows $28.2M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review MAIA Biotechnology source filings ↗